International guidelines

Rest of the world

NCCN clinical practice guidelines in oncology: head and neck cancers[2]

Published by:National Comprehensive Cancer Network

Last published:2024

Radiation therapy for HPV-positive oropharyngeal squamous cell carcinoma[90]

Published by:American Society for Radiation Oncology

Last published:2024

Prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy[118]

Published by:The International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and American Society of Clinical Oncology

Last published:2024

NCCN clinical practice guidelines in oncology: management of immunotherapy-related toxicities[112]

Published by:National Comprehensive Cancer Network

Last published:2024

ACR appropriateness criteria: staging and post-therapy assessment of head and neck cancer[73]

Published by:American College of Radiology

Last published:2023

Expert consensus statement: management of dysphagia in head and neck cancer patients[113]

Published by:American Society of Clinical Oncology

Last published:2023

Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers[114]

Published by:American Society of Clinical Oncology

Last published:2022

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[74]

Published by:European Society for Medical Oncology

Last published:2020

Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx[115]

Published by:American Society of Clinical Oncology

Last published:2019

Radiation therapy for oropharyngeal squamous cell carcinoma[116]

Published by:American Society of Clinical Oncology

Last published:2017

ACR appropriateness criteria: locoregional therapy for resectable oropharyngeal squamous cell carcinomas[117]

Published by:American College of Radiology

Last published:2016

Use of this content is subject to our disclaimer